One day, two deals and a changed calculus of deal-making

Steven Davidoff Solomon writes for The New York Times, November 17, 2014

It has been awhile since we’ve seen a deal day like Monday, with Halliburton announcing that it had reached a $34.6 billion deal to buy Baker Hughes and Allergan selling itself to Actavis for $66 billion. The deals show that the merger and acquisitions market is changing in some obvious and not so obvious ways that may change how companies are bought and sold.